• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Orthobiologics

Bioventus bolsters bone healing lineup

October 14, 2014 By Alexander Soule Leave a Comment

Bioventus bolsters bone healing lineup

Bioventus said it acquired the OsteoAMP product line from Advanced Biologics for an undisclosed amount.

OsteoAMP is a tissue-based product used to promote natural bone growth and healing in the spine, according to a press release.

Filed Under: Mergers & Acquisitions, News Well Tagged With: Advanced Biologics, Bioventus LLC, Orthobiologics, Smith & Nephew

Zimmer adds Harvard spinout Etex Corp.

October 2, 2014 By Alex Soule Leave a Comment

Zimmer adds Harvard spinout Etex Corp.

Zimmer (NYSE:ZMH) said yesterday that it paid an unspecified amount for Etex Corp. and the bone biomaterials it’s developing in Cambridge, Mass.

Filed Under: Mergers & Acquisitions, News Well, Orthopedics Tagged With: ETEX Corp., Orthobiologics, Zimmer Biomet

Appeals court vacates FDA’s rescission of ReGen’s MenaFlex implant

September 29, 2014 By Brad Perriello Leave a Comment

Appeals court vacates FDA's rescission of ReGen's MenaFlex implant

Filed Under: Food & Drug Administration (FDA), Legal News, News Well Tagged With: Orthobiologics, ReGen Biologics Inc., U.S. Congress

Olympus concedes biotech defeat, shutters OP-1 plant

June 18, 2014 By Brad Perriello Leave a Comment

Olympus concedes biotech defeat, shutters OP-1 plant

Filed Under: Biotech, News Well, Wall Street Beat Tagged With: Olympus, Orthobiologics, Stryker

GE gets behind Cerapedics and its i-FACTOR bone graft

April 21, 2014 By Arezu Sarvestani Leave a Comment

GE gets behind Cerapedics and its i-FACTOR bone graft

Tech and healthcare giant GE (NYSE:GE) put some skin in Cerapedics and its i-FACTOR bone graft, funding a $9 million venture debt financing round for the Colorado-based company.

Filed Under: Funding Roundup, News Well Tagged With: Cerapedics Inc., GE Healthcare, Orthobiologics, Resorbable bone materials

FzioMed turns to FDA’s Dispute Panel to contest Oxiplex denial

April 14, 2014 By Arezu Sarvestani Leave a Comment

FzioMed gets a date with the FDA

Once-scorned biomaterials maker FzioMed is getting another day with the FDA to discuss its Oxiplex spinal surgery gel, which was rejected by U.S. healthcare officials in 2008.

FzioMed will meet June 10, 2014, with the FDA’s Medical Device Dispute Resolution Panel to discuss the "approvability" of the Oxiplex gel, which has been on the European market since 2012 and is approved for sale in 70 countries. The product has already been used in more than 350,000 surgeries, FzioMed said.

Filed Under: Food & Drug Administration (FDA), News Well, Spine Tagged With: FzioMed, Orthobiologics

Pessimistic Wright Medical wins FDA date for Augment

February 25, 2014 By Brad Perriello Leave a Comment

Pessimistic Wright Medical wins FDA date for Augment

Wright Medical (NSDQ:WMGI) said it’s not optimistic about an FDA dispute resolution panel on its Augment biologic bone graft product, now slated for May, and would quickly move to cut costs at the BioMimetic Therapeutics subsidiary it bought back in 2012.

Filed Under: MassDevice Earnings Roundup, News Well, Orthopedics Tagged With: 2013, BioMimetic Therapeutics Inc., Orthobiologics, Q4, wrightmedical

GPOs: Mazor, RTI Surgical land supply deals

January 21, 2014 By Chris Walker Leave a Comment

GPOs: Mazor, RTI Surgical land supply deals

Mazor Robotics (NSDQ:MZOR) announced a deal with an unnamed group purchasing organization for its flagship Renaissance robotic surgery system.

Filed Under: News Well, Spine, Surgical Robotics Tagged With: Group Purchasing Organizations (GPO), mazorrobotics, Orthobiologics, RTI Surgical, Yankee Health Members

Another lawsuit against Medtronic’s Infuse proceeds in Arizona

August 27, 2013 By Arezu Sarvestani Leave a Comment

Another lawsuit against Medtronic's Infuse proceeds in Arizona

Filed Under: Legal News, News Well, Orthopedics, Spine Tagged With: Orthobiologics, Personal Injury, Resorbable bone materials

Conflicting decisions and new tactics in Medtronic Infuse lawsuits

August 8, 2013 By Arezu Sarvestani Leave a Comment

Preemption saves Medtronic in Infuse bone-growth protein lawsuit

Filed Under: Legal News, News Well, Orthopedics, Spine Tagged With: Minnesota, Orthobiologics, Personal Injury, Resorbable bone materials

Long-awaited ruling in Medtronic Infuse lawsuit could have ripple effect on industry

July 10, 2013 By Arezu Sarvestani Leave a Comment

Medtronic logo

Federal pre-emption statutes have thus far stalled personal injury complaints over Medtronic’s (NYSE:MDT) troubled Infuse bone-growth protein, but new lawsuits may find their way to trial by claiming that the medtech titan is liable for injuries because it engaged in off-label marketing.

Filed Under: Legal News, News Well, Orthopedics, Spine Tagged With: Minnesota, Orthobiologics, Resorbable bone materials

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 5
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy